Skip to main content

Table 2 Pathological findings

From: Impact of the new guidelines of the American Thyroid Association on the treatment of the differentiated thyroid tumor in an Italian center with medium-high volume thyroid surgery

All patients (2014–2016) 197
Total thyroidectomy 194
Lobohystmectomy 3
Neoplastic disease 46/197 (23.3%)
- Preoperative malignant cytology 28/46 (60.9%)
- Incidental malignant disease 18/46 (39.1%)
Hystotype
- Papillary carcinoma 42/46 (91.4%)
- Follicular carcinoma 2/46 (4.3%)
- Hurtle cells carcinoma 2/46 (4.3%)
Multifocal neoplastic disease 4/46 (8.7%)
Benign disease 151 (76.7%)